Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

BDX

BECTON DICKINSN

NYSE

Real-time Quotes | Nasdaq Last Sale

253.82

-2.98

-1.16%

After Hours: 255.16 +1.34 +0.53% 16:56 09/23 EDT

OPEN

257.38

PREV CLOSE

256.80

HIGH

258.36

LOW

253.46

VOLUME

1.60M

TURNOVER

52 WEEK HIGH

267.37

52 WEEK LOW

219.50

MARKET CAP

72.89B

P/E (TTM)

39.86

BD Joins the Race to Zero: Largest Alliance Dedicated to Achieving Net Zero Emissions by 2050

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Global Citizen, is proud to announce the company has officially signed on to the Race to Zero via the most ambitio...

PR Newswire · 1d ago

Injectable Drug Delivery Market Influenza Diagnostics Market Research Report for Complete Analysis of Current Scenario 2020 – 2028

The scope of the report includes a detailed study of global and regional markets on Global Injectable Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.

Heraldkeepers · 2d ago

Flow Cytometry Market 2021-2025: Industry Analysis, Market Trends, Market Growth, Opportunities & Forecast

The Global Flow Cytometry Market is expected to exceed more than US$ 5.50 Billion by 2024 at a CAGR of 9.5% in the given forecast period.

Heraldkeepers · 2d ago

BRIEF-BD Partners With Washington State In Back-To-School Testing Effort

reuters.com · 2d ago

BD Partners with Washington State in Back-to-School Testing Effort

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of as a digitally read, rapid antigen test option for COVID-19 testing and screening in K-12 sch...

PR Newswire - PRF · 2d ago

Becton Dickinson to Provide COVID-19 Rapid Test Kits for Washington State Schools

MT Newswires · 2d ago

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Zacks.com · 6d ago

UPDATE: $142M PIPE Deal Supporting Vicarious Surgical Business Includes Strategic Investments From Becton Dickinson And New Frontier Health Corporation

The total $142 million PIPE supporting the transaction is funded by multiple strategic investors including global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), major hospital groups

Benzinga · 09/15 20:53

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of BDX. Analyze the recent business situations of BECTON DICKINSN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BDX stock price target is 267.80 with a high estimate of 285.00 and a low estimate of 250.00.

EPS

Institutional Holdings

Institutions: 1.96K

Institutional Holdings: 267.75M

% Owned: 93.23%

Shares Outstanding: 287.19M

TypeInstitutionsShares

Increased

544

13.38M

New

2.07M

Decreased

562

11.80M

Sold Out

115

2.43M

Performance
Asset Allocation
Dividend History

No Data

Industry

Medical Equipment, Supplies & Distribution

+0.88%

Healthcare Equipment & Supplies

+0.77%

Key Executives

Chairman/President/Chief Executive Officer/Chief Operating Officer/Director

Thomas Polen

Chief Financial Officer/Executive Vice President

Christopher DelOrefice

Corporate Executive

David Hickey

Chief Human Resource Officer/Executive Vice President/Director of Human Resources

Betty Larson

Executive Vice President/Chief Administrative Officer

Christopher Reidy

Executive Vice President

Simon Campion

Executive Vice President

Alexandre Conroy

Executive Vice President

Roland Goette

Executive Vice President

Samrat Khichi

Executive Vice President

James Lim

Executive Vice President

Alberto Mas

Chief Accounting Officer/Vice President/Controller

Thomas Spoerel

Lead Director/Independent Director

Marshall Larsen

Independent Director

Catherine Burzik

Independent Director

R. Andrew Eckert

Independent Director

Claire Fraser

Independent Director

Jeffrey Henderson

Independent Director

Christopher Jones

Independent Director

David Melcher

Independent Director

Claire Pomeroy

Independent Director

Rebecca Rimel

Independent Director

Timothy Ring

Independent Director

Bertram Scott

Declaration Date Dividend Per Share Ex-Div Date: 07/27/2021
Dividend USD 0.83
09/08/2021; 04/27/2021
Dividend USD 0.83
06/08/2021; 01/25/2021
Dividend USD 0.83
03/09/2021; 11/24/2020
Dividend USD 0.83
12/09/2020; 07/27/2020
Dividend USD 0.79
09/08/2020; 04/28/2020
Dividend USD 0.79
06/08/2020; 01/27/2020
Dividend USD 0.79
03/09/2020; 11/25/2019
Dividend USD 0.79
12/09/2019; 07/22/2019
Dividend USD 0.77
09/06/2019; 04/29/2019
Dividend USD 0.77
06/06/2019; 01/21/2019
Dividend USD 0.77
03/07/2019; 11/19/2018
Dividend USD 0.77
12/07/2018; 07/24/2018
Dividend USD 0.75
09/06/2018; 04/23/2018
Dividend USD 0.75
06/07/2018; 01/23/2018
Dividend USD 0.75
03/08/2018; 11/21/2017
Dividend USD 0.75
12/07/2017; 07/27/2017
Dividend USD 0.73
09/07/2017; 05/24/2017
Dividend USD 0.73
06/07/2017; 01/24/2017
Dividend USD 0.73
03/08/2017; 11/22/2016
Dividend USD 0.73
12/07/2016

All
Financials
Insiders

About BDX

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform.